|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,455.00 GBX | +0.69% |
|
+3.78% | -6.13% |
| 05-15 | Hikma Pharmaceuticals PLC Announces Change of Registered Office Address | CI |
| 05-08 | Hikma Pharmaceuticals Usa Inc. Announces Recall of Alendronate Sodium Oral Solution | CI |
| Capitalization | 4.19B 3.61B 3.31B 3.13B 5.76B 405B 5.91B 39.43B 15.35B 191B 15.71B 15.38B 666B | P/E ratio 2026 * |
10.1x | P/E ratio 2027 * | 9.15x |
|---|---|---|---|---|---|
| Enterprise value | 5.57B 4.81B 4.4B 4.16B 7.67B 540B 7.87B 52.49B 20.44B 254B 20.92B 20.47B 887B | EV / Sales 2026 * |
1.61x | EV / Sales 2027 * | 1.49x |
| Free-Float |
64.53% | Yield 2026 * |
4.4% | Yield 2027 * | 4.65% |
Last Transcript: Hikma Pharmaceuticals PLC
| 1 day | +0.69% | ||
| 1 week | +3.78% | ||
| Current month | +4.04% | ||
| 1 month | +5.51% | ||
| 3 months | -11.28% | ||
| 6 months | -7.74% | ||
| Current year | -6.13% |
| 1 week | 1,402 |  | 1,475.33 |
| 1 month | 1,311 | | 1,475.33 |
| Current year | 1,187 | | 1,691 |
| 1 year | 1,187 | | 2,164 |
| 3 years | 1,187 | | 2,360 |
| 5 years | 1,174.5 | | 2,703 |
| 10 years | 814.2 | | 2,768 |
| Manager | Title | Age | Since |
|---|---|---|---|
Said Darwazah
CEO | Chief Executive Officer | 69 | 30/11/2025 |
Areb Kurdi
DFI | Director of Finance/CFO | - | 25/02/2026 |
| Chief Tech/Sci/R&D Officer | 64 | 25/02/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 69 | 13/10/2005 | |
Khalid Nabilsi
BRD | Director/Board Member | 54 | 14/12/2025 |
Said Darwazah
CHM | Chairman | 69 | 14/05/2014 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | +4.49% | 0.16% | 27 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.69% | +3.78% | -29.64% | -20.32% | 4.16B | |
| +3.37% | +3.19% | +35.27% | +130.89% | 881B | |
| +0.47% | +2.56% | +50.83% | +44.74% | 551B | |
| +2.08% | +2.84% | +15.10% | +47.31% | 370B | |
| +0.88% | +0.40% | +24.15% | +11.99% | 327B | |
| +1.24% | +0.96% | +33.82% | +15.57% | 285B | |
| +1.57% | +2.71% | +30.03% | +31.52% | 284B | |
| +1.49% | +1.66% | +47.92% | -1.08% | 278B | |
| +0.52% | -3.04% | -34.47% | -50.00% | 197B | |
| +1.96% | -1.65% | +19.90% | +48.04% | 175B | |
| Average | +1.43% | +1.50% | +19.29% | +25.87% | 335.28B | |
| Weighted average by Cap. | +1.77% | +2.06% | +30.01% | +51.58% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.47B 2.99B 2.74B 2.59B 4.77B 336B 4.89B 32.65B 12.71B 158B 13.01B 12.73B 552B | 3.63B 3.13B 2.87B 2.71B 5B 352B 5.13B 34.21B 13.32B 166B 13.63B 13.34B 578B |
| Net income | 414M 357M 327M 309M 570M 40.12B 585M 3.9B 1.52B 18.89B 1.56B 1.52B 65.96B | 454M 391M 358M 339M 624M 43.93B 640M 4.27B 1.66B 20.68B 1.7B 1.67B 72.21B |
| Net Debt | 1.39B 1.2B 1.1B 1.04B 1.91B 134B 1.96B 13.06B 5.09B 63.22B 5.21B 5.09B 221B | 1.23B 1.06B 973M 919M 1.7B 119B 1.74B 11.6B 4.52B 56.13B 4.62B 4.52B 196B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 19/05/26 | 1,455.00 p | +0.69% | 1,107,138 |
| 18/05/26 | 1,445.00 p | +0.35% | 422,356 |
| 15/05/26 | 1,440.00 p | +1.12% | 1,239,990 |
| 14/05/26 | 1,424.00 p | +0.14% | 557,310 |
| 13/05/26 | 1,422.00 p | +1.43% | 595,120 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- HIK Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition